文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Leukemia Department, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 428, Houston, TX 77030, USA.

Hematology. 2012 Apr;17 Suppl 1:S52-4. doi: 10.1179/102453312X13336169155538.

Monoclonal antibodies targeting surface markers in acute lymphocytic leukemia (CD19, CD20 and CD22) are showing promising results and are reviewed.

靶向急性淋巴细胞白血病表面标志物（CD19、CD20和CD22）的单克隆抗体正显示出有前景的结果，并在此进行综述。

Leukemia Department, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 428, Houston, TX 77030, USA.

Hematology. 2012 Apr;17 Suppl 1:S52-4. doi: 10.1179/102453312X13336169155538.

Monoclonal antibodies targeting surface markers in acute lymphocytic leukemia (CD19, CD20 and CD22) are showing promising results and are reviewed.

靶向急性淋巴细胞白血病表面标志物（CD19、CD20和CD22）的单克隆抗体正显示出有前景的结果，并在此进行综述。